Drugs / LX7101
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01528111 | Mar → Jun 2012 | ocular hypertension, open-angle glaucoma | Lexicon Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LX7101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01528111 ↗ |
| Modality | Small molecule | — CHEMBL3356433 ↗ |
| Route | Topical | “Topically administered LX7101” NCT01528111 ↗ |